Optimal Therapeutic Strategy Using Sacubitril/Valsartan in a Patient with Systolic Heart Failure and Chronic Kidney Disease - An Initial Case Report in Japan

Sacubitril/valsartan has demonstrated its prognostic advantageousness over enalapril in patients with heart failure with a reduced ejection fraction. However, the optimal therapeutic strategy using sacubitril/valsartan in real-world practice, particularly among a Japanee cohort, remains uncertain. A...

Descripción completa

Detalles Bibliográficos
Autores principales: Imamura, Teruhiko, Hori, Masakazu, Kinugawa, Koichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8479222/
https://www.ncbi.nlm.nih.gov/pubmed/34470986
http://dx.doi.org/10.2169/internalmedicine.6713-20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8479222/
https://www.ncbi.nlm.nih.gov/pubmed/34470986
http://dx.doi.org/10.2169/internalmedicine.6713-20

Ejemplares similares